Meclon (Clotrimazole, Metronidazole)

Clotrimazole interferes with fungal cell membrane formation by inhibiting the enzyme lanosterol 14α‑demethylase, which blocks ergosterol synthesis. Metronidazole is taken up by anaerobic bacteria and reduced to nitro radicals that damage DNA and halt nucleic acid synthesis. Together they provide simultaneous antifungal and antibacterial activity within the vagina.

The dosage regimen for Meclon is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The product is supplied as a vaginal formulation, and the prescriber will specify the amount to be applied, frequency, and duration of therapy.

Safety data for Meclon in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will assess individual circumstances before recommending treatment.

To order Meclon, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with single‑agent products such as clotrimazole alone, Meclon offers broader coverage by also targeting anaerobic bacteria through metronidazole. This dual action can be advantageous in mixed infections, reducing the need for separate antifungal and antibacterial prescriptions, while maintaining a similar safety profile to each component used individually.

Meclon should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme heat. Keep it out of reach of children and do not use if the packaging is damaged or the product appears discoloured.

Meclon is applied intravaginally as directed by a healthcare professional. The prescribed amount is typically inserted into the vagina using the supplied applicator or a clean fingertip, ensuring even distribution over the vaginal walls. The treatment course length and frequency are defined by the prescriber.

Serious risks include hypersensitivity reactions such as rash, swelling, or hives, and rare but severe vaginal ulceration or necrosis. Systemic effects like Clostridioides difficile infection or significant liver enzyme elevations may occur, especially in patients with pre‑existing liver disease or prolonged exposure.

Meclon should be avoided in individuals with a known allergy to clotrimazole, metronidazole, or any component of the formulation. It is also contraindicated in patients with severe liver impairment or those who are pregnant or breastfeeding unless the prescriber determines that the benefits outweigh the risks.